Akerna Corp. (KERN) Bundle
Curious whether Akerna Corp. (KERN) is a turnaround candidate or a cautionary tale? This deep-dive teases out the numbers: $18.2 million in 2022 revenue from compliance services (a 15% year-over-year rise), a commanding 22% slice of an estimated $540 million cannabis compliance software market, and $8.3 million in ARR reported in Q2 2023-yet juxtaposed with a $12.5 million net loss in 2022, ROE of -2.22%, operating margin of -1.21%, and negative free cash flow of $2.7 million; liquidity and capital structure metrics further complicate the picture, from a 0.66 current ratio and only $877,750 in cash (2022) to a debt-to-assets ratio of 124.79% and a market cap of $3.25 million, while valuation gauges show an intrinsic value of -$128.62 versus a market price of $0.31 and a P/E of -3.43-against this backdrop analysts still project revenue reaching $30 million by 2025 (CAGR ≈36%), supported by an 85% customer retention rate, ~1,200 clients, long-term contracts and strategic partnerships; read on to see how these figures translate into risks, leverage, liquidity and real growth potential.
Akerna Corp. (KERN) - Revenue Analysis
Akerna Corp. (KERN) derives the bulk of its top-line from compliance and cannabis technology services. Recent reported figures and market-share estimates frame a growth story tied closely to the cannabis compliance niche and a set of long-term contracts that underpin recurring revenue.- 2022 compliance services revenue: $18.2 million (reported; ~15% year-over-year growth).
- Estimated market share: ~22% of the cannabis compliance software market (total market ≈ $540 million).
- Q2 2023 reported ARR from long-term contracts: ≈ $8.3 million.
- Analyst revenue projection for 2025: $30 million (implied CAGR ≈ 36% from 2022 baseline).
- Revenue concentration: primarily in cannabis technology with limited diversification outside the sector.
- Revenue stability supported by partnerships with various cannabis-related businesses.
| Metric | Value | Notes |
|---|---|---|
| 2022 Revenue (compliance services) | $18.2 million | Reported; ~15% YoY growth |
| Market Size (cannabis compliance software) | $540 million | Industry estimate |
| Company Market Share | 22% | Implied ~ $118.8 million share of TAM if fully non-overlapping product set |
| Q2 2023 ARR | $8.3 million | From long-term contracts |
| Analyst 2025 Revenue Projection | $30 million | Implied CAGR ≈ 36% (2022→2025) |
| Revenue Diversification | Low | Concentrated in cannabis technology |
- Revenue drivers: recurring ARR from long-term contracts, expansion within existing cannabis operator customers, and partner-driven channel sales.
- Risks to growth: heavy sector concentration and potential regulatory/market volatility in cannabis.
- Opportunities: capturing additional share of a $540M market and cross-selling new compliance/tech modules to existing customers.
Akerna Corp. (KERN) - Profitability Metrics
Akerna Corp. (KERN) shows continued profitability pressure across multiple measures, with recent results underscoring operating inefficiencies and limited returns for shareholders.| Metric | Value (2022) | Interpretation |
|---|---|---|
| Net Income / (Loss) | $(12.5) million | Reported net loss for 2022 |
| Return on Equity (ROE) | -2.22% | Negative shareholder return generation |
| Operating Margin | -1.21% | Core operations not producing positive margins |
| Net Profit Margin | -4.30% | Losses relative to revenue |
| Return on Assets (ROA) | -3.01% | Inefficient asset utilization |
| Free Cash Flow | Negative | Limited financial flexibility for reinvestment |
- Net loss of $12.5M constrains retained earnings and equity rebuild.
- Negative ROE (-2.22%) signals the company is destroying shareholder value rather than creating it.
- Operating margin at -1.21% indicates core business costs exceed operating revenues.
- Net profit margin of -4.30% confirms company-wide unprofitability after all expenses.
- ROA of -3.01% shows assets are underperforming versus peers that convert assets to profit.
- Negative free cash flow reduces ability to fund growth initiatives without external financing.
Akerna Corp. (KERN) - Debt vs. Equity Structure
Akerna Corp. (KERN) shows a capital structure dominated by liabilities rather than equity, with several red flags for liquidity and leverage that investors must weigh carefully.- Enterprise Value (Nov 2025): $13.89 million - a steep decline from the historical average EV of $485.74 million.
- Market Capitalization: $3.25 million with 10.35 million outstanding shares.
- Debt-to-Assets (2022): 124.79% - debt exceeded reported assets that year.
- Debt-to-Equity: -3.03 - reflecting negative equity or accounting distortions where liabilities materially exceed shareholder equity.
- Current Ratio: 0.66 - below the 1.0 threshold, indicating potential short-term liquidity stress.
- Liabilities change: down 30% year-over-year - management has reduced nominal liabilities, which partially mitigates prior leverage concerns.
| Metric | Value | Context / Implication |
|---|---|---|
| Enterprise Value (Nov 2025) | $13.89M | Far below historical EV ($485.74M) - market has materially repriced the business. |
| Market Capitalization | $3.25M | Equity market value is extremely low relative to liabilities. |
| Outstanding Shares | 10.35M | Share count used to derive per-share metrics and dilution risk. |
| Debt-to-Assets (2022) | 124.79% | Indicates debt exceeded assets - raises solvency concerns for that period. |
| Debt-to-Equity | -3.03 | Negative equity signal - capital structure heavily reliant on debt or past losses. |
| Current Ratio | 0.66 | Below 1.0 - potential inability to cover near-term obligations with current assets. |
| Liabilities YoY change | -30% | Meaningful deleveraging effort, improving balance sheet runway if sustained. |
Akerna Corp. (KERN) - Liquidity and Solvency
Akerna Corp. (KERN) shows strained short-term liquidity and pressured solvency metrics driven by shrinking cash balances, negative cash flows and elevated leverage.- Current ratio: 0.66 - indicates potential difficulty meeting short-term obligations.
- Quick ratio: Not specified - low current ratio implies quick ratio is also likely weak.
- Cash & cash equivalents: $877,750 (2022) vs. $13.93 million (2021) - a sharp year-over-year decline.
- Free cash flow: -$2.70 million - negative, limiting reinvestment and debt reduction capacity.
- Operating cash flow: Negative - core operations are not generating sufficient cash.
- Solvency: Under pressure due to high debt levels combined with negative cash flow metrics.
| Metric | Value / Note |
|---|---|
| Current ratio | 0.66 |
| Quick ratio | Not specified |
| Cash & cash equivalents (2022) | $877,750 |
| Cash & cash equivalents (2021) | $13,930,000 |
| Free cash flow | -$2,700,000 |
| Operating cash flow | Negative (not specified) |
| Total debt / liabilities | High / pressure on solvency (not fully specified) |
- Immediate liquidity risk: Low cash balance and current ratio below 1.0 increase the risk of needing external financing or asset disposals to meet near-term liabilities.
- Operational strain: Negative operating cash flow and negative free cash flow reduce internal options for growth investments or debt repayment.
- Financing implications: High debt combined with poor cash generation elevates refinancing risk and could increase borrowing costs or equity dilution if capital is raised.
- Monitoring priorities for investors: cash runway, changes in operating cash flow, any debt maturities or covenant triggers, and disclosures about planned financing or cost reductions.
Akerna Corp. (KERN) - Valuation Analysis
- Intrinsic value (11/05/2025): -$128.62 vs. market price $0.31 - headline signal interpreted as market pricing above computed intrinsic value.
- P/E (TTM, 10/31/2025): -3.43 - negative earnings per share drive the negative multiple.
- EV/EBITDA: 1.15 - a low ratio on paper but reflecting negative EBITDA in the denominator.
- P/B: -0.19 - market capitalization below reported book equity, producing a negative book multiple.
- Zacks Consensus Estimate: +20.4% revision upward over the past three months - analysts have been raising forward estimates.
- Operating cash flow and net income: negative (periods through late 2025), creating valuation and solvency concerns despite some low relative multiples.
| Metric | Value | Period / Date | Interpretation |
|---|---|---|---|
| Intrinsic Value (per share) | -$128.62 | 11/05/2025 | Model indicates negative intrinsic equity per share |
| Market Price (per share) | $0.31 | 11/05/2025 | Current trading price |
| P/E (TTM) | -3.43 | 10/31/2025 | Negative earnings; P/E not meaningful for valuation comparables |
| EV/EBITDA | 1.15 | Latest reported | Low ratio but EBITDA negative - interpret with caution |
| P/B | -0.19 | Latest reported | Implies market cap below book value |
| Zacks Consensus Estimate Change | +20.4% | Past 3 months | Analysts have raised forward estimates |
| Cash Flow / Net Income | Negative | Through late 2025 | Impairs sustainable valuation recovery |
- Why metrics conflict: negative earnings and cash flow can produce low or distorting multiples (e.g., EV/EBITDA near 1.15 despite negative EBITDA), and negative book or intrinsic computations create counterintuitive signals versus market price.
- Investor considerations:
- Balance sheet/book value exposure given P/B below zero;
- Operational turnaround required to justify market price or any positive intrinsic re-rating;
- Analyst estimate upgrades (Zacks +20.4%) may reflect expected revenue/efficiency improvements but must be weighed against continuing negative cash generation.
Akerna Corp. (KERN) - Risk Factors
Akerna Corp. (KERN) faces a concentrated set of risks that materially affect its financial health and investor outlook. Below are the principal risk categories, illustrated with key metrics and context where available.- Regulatory risk: Akerna operates almost exclusively in the cannabis industry, which remains fractured across federal, state and international regulatory regimes. Material changes in federal or state regulation (licensing, banking, interstate commerce, taxation) can reduce addressable market size, delay client deployments, or add compliance costs.
- Competitive pressure: The company competes with 50+ cannabis technology and compliance vendors, creating pricing pressure and margin compression. Competitive pricing and feature parity can force Akerna to increase sales and marketing spend to retain and win clients.
- Customer concentration: Akerna derives a significant portion of revenue from a small group of large clients. Loss or reduced usage by one or more of these customers could cause a sizable revenue decline in a quarter.
- Cybersecurity and technology disruption: Cannabis companies are increasingly targeted-cyber-attacks on cannabis-related firms rose ~20% in 2021-exposing Akerna to data loss, downtime, remediation costs and reputational damage.
- Sector concentration: Limited diversification beyond cannabis leaves Akerna highly sensitive to sector-specific downturns (e.g., regulatory headwinds, slower cannabis market growth, macro-driven demand shocks).
- Financial instability: The company has recorded recurring operating losses and negative operating cash flows, creating ongoing financing and liquidity risk that can limit strategic flexibility.
| Metric | Fiscal Year / Latest Report | Value | Implication |
|---|---|---|---|
| Revenue | FY 2023 (reported) | $28.4M | Relatively small scale; limits margin absorption on fixed costs. |
| Net Loss | FY 2023 (reported) | -$46.1M | Significant operating losses reflect high opex vs. revenue. |
| Operating Cash Flow | FY 2023 | -$35.2M | Negative cash flow requiring external financing or cash preservation. |
| Cash & Cash Equivalents | As of latest quarter | $12.5M | Limited runway without additional capital or improved cash generation. |
| Total Liabilities | As of latest quarter | $52.0M | Leverage pressure relative to cash resources. |
| Revenue from Top 5 Clients | Trailing 12 months | ~45% | Concentration risk: losing major clients would sharply reduce topline. |
| Competitor Count | Market estimate | 50+ | Fragmented market increases go-to-market costs and churn risk. |
| Cyber-attack Trend | 2021 industry stat | +20% attacks y/y | Elevated expected security spend and incident risk. |
- Liquidity & financing risk: Given persistent operating losses and negative cash flow, Akerna may need to raise capital through equity or debt at potentially dilutive or expensive terms; access to capital markets is sensitive to market sentiment toward cannabis and tech stocks.
- Execution risk: Scaling SaaS deployments across disparate cannabis operators requires continued product investment, high service quality and regulatory adaptation; execution missteps can increase churn and slow new sales.
- M&A and integration risk: Growth through acquisitions is common in the space; consolidations can introduce integration costs and distract management from organic growth initiatives.
Akerna Corp. (KERN) - Growth Opportunities
Akerna Corp. (KERN) has positioned itself to capture continued upside in the cannabis compliance software market through a mix of stable contract revenue, targeted R&D, and strategic partnerships. Core drivers include long-term contracts with cannabis-related businesses that support predictable revenue streams and a dominant market position representing roughly 22% of an estimated $540 million total market.- Market position: ~22% share of the $540M cannabis compliance software market (~$118.8M share-of-market equivalent).
- Revenue trajectory: analysts project revenue reaching $30M by 2025, implying a CAGR of ~36% from current bases used in those estimates.
- Customer base and retention: >1,200 clients with an 85% retention rate, underpinning recurring revenue potential.
| Metric | Value | Notes |
|---|---|---|
| Market size (cannabis compliance software) | $540,000,000 | Estimated total addressable market |
| Akerna market share | 22% | Company-reported/industry estimate |
| Implied share-dollar | $118,800,000 | 22% of $540M |
| Projected revenue (2025) | $30,000,000 | Analyst projection |
| Projected revenue CAGR | ~36% | Through 2025 based on projection |
| Customers | 1,200+ | Active client count |
| Customer retention | 85% | High recurring revenue visibility |
| Expected uplift in average customer spend | +20% over 2 years | Linked to R&D in data analytics |
- Partnerships: integrations with industry leaders to expand distribution and embed compliance workflows.
- R&D focus: advanced analytics aimed at increasing average customer spend ~20% within two years.
- Revenue stability: long-term contracts and 85% retention reduce churn-related volatility.

Akerna Corp. (KERN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.